New York, FTC sue 'pharma bro' Shkreli, others over Daraprim price hikes

New York, FTC sue
New York, FTC sue 'pharma bro' Shkreli, others over Daraprim price hikes  

By Diane Bartz

WASHINGTON (Reuters) - Martin Shkreli, the "pharma bro" in prison for defrauding investors, faces a lawsuit filed by the Federal Trade Commission and New York Attorney General's office for a scheme to preserve his monopoly for the drug Daraprim, which saw its price increase by more than 4,000% in one day.

The lawsuit accuses a company Shkreli once ran of buying the rights in 2015 to Daraprim, which is used to treat toxoplasmosis, and quickly raising the price from $17.50 per tablet to $750 while taking steps to ensure that there would not be a cheaper generic version of the medicine.

The company named is Vyera Pharmaceuticals, formerly Turing Pharmaceuticals, which was headed by Shkreli.

The lawsuit also names Shkreli associate Kevin Mulleady, the FTC said. The FTC and New York attorney general's office are seeking monetary relief for people who overpaid for the medicine and an order requiring the company to halt illegal conduct.

Shkreli, who is in prison in Pennsylvania, became notorious as "Pharma Bro" when he sharply raised the price of the anti-parasitic drug Daraprim while chief executive of Turing Pharmaceuticals.

A spokeswoman for Vyera and a lawyer for Shkreli, 36, did not immediately respond to a request for comment. Shkreli is slated for release in September 2023, according to the Federal Bureau of Prisons.

"We filed this lawsuit to stop Vyera's egregious conduct, make the company pay for its illegal scheming, and block Martin Shkreli from ever working in the pharmaceutical industry again. We won't allow 'pharma bros' to manipulate the market and line their pockets at the expense of vulnerable patients and the health care system," New York Attorney General Letitia James said in a statement.

James said Vyera raised the price of the drug by more than 4,000% in a single day.

The FTC alleged that the company protected its dominance of the drug by restricting distribution to ensure generic drug makers could not get the samples needed to make their own version of the drug. The company also prevented potential competitors from buying one of the medicine's ingredients, the FTC said.

The U.S. Supreme Court said in November that Shkreli must remain in prison, rejecting his effort to overturn his conviction and seven-year sentence for securities fraud and conspiracy.

The justices refused to hear Shkreli's appeal of his August 2017 conviction and $7.36 million forfeiture for cheating investors in two hedge funds he founded, and trying to prop up the stock price of biotechnology company Retrophin Inc <RTRX.O>, which he once ran.

(Reporting by Diane Bartz; Editing by David Gregorio)


More Related News

New York State AG
New York State AG's New Plan Would Strip NYPD Control from Mayor de Blasio: Report

Citing weeks of protests as having shaken faith in the NYPD, New York State attorney general Letitia James recommended stripping New York City mayor Bill de Blasio's authority in law-enforcement matters in a new report released Wednesday. James has called to end the mayor's ability to appoint the police commissioner and to oversee the hiring and firing of officers. The state attorney general instead recommended granting that power to an independent panel made up of representatives appointed by the City Council, the mayor's office, the city's public advocate, and the city comptroller's office. "It is impossible to deny that many New Yorkers have lost faith in law enforcement," James told...

New oversight committee would restore faith in NYPD, AG says
New oversight committee would restore faith in NYPD, AG says

New York Attorney General Letitia James proposed sweeping changes Wednesday to boost oversight of the New York City Police Department, including forming an independent commission that would approve the department's budget and have the final say on officer discipline. "The police should not police themselves - period," James, a Democrat, told reporters. Gov. Andrew Cuomo asked James to investigate whether NYPD officers used excessive force to quell unrest and enforce a citywide curfew in the wake of George Floyd's death in Minneapolis.

New York AG says police reforms should be
New York AG says police reforms should be 'quickly' enacted amid protest investigation
  • US
  • 2020-07-08 20:31:34Z

In a 57-page report, New York Attorney General Letitia James provides a series of police reforms that should be enacted following the protests.

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply


Top News: Economy